Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Ps Multiple | 0.9x - 1.0x | 1.0x |
Selected Fwd Ps Multiple | 0.9x - 1.0x | 0.9x |
Fair Value | CHF 11.71 - CHF 12.95 | CHF 12.33 |
Upside | 26.6% - 39.9% | 33.2% |
Benchmarks | Ticker | Full Ticker |
---|---|---|
Sika AG | - | SWX:SIKA |
Givaudan SA | - | SWX:GIVN |
DSM-Firmenich AG | - | ENXTAM:DSFIR |
Elementis plc | - | DB:E3E |
Akzo Nobel N.V. | - | ENXTAM:AKZA |
Clariant AG | - | BATS-CHIXE:CLNz |
Select Price / LTM Sales Ratio | ||||||||
Benchmark Companies | ||||||||
SIKA | GIVN | DSFIR | E3E | AKZA | CLNz | |||
SWX:SIKA | SWX:GIVN | ENXTAM:DSFIR | DB:E3E | ENXTAM:AKZA | BATS-CHIXE:CLNz | |||
Historical Sales Growth | ||||||||
5Y CAGR | 7.7% | 3.6% | 9.9% | -3.3% | 2.9% | -1.1% | ||
3Y CAGR | 8.3% | 3.5% | 20.8% | 1.3% | 3.8% | -1.7% | ||
Latest Twelve Months | 4.7% | 7.2% | 20.4% | 3.5% | 0.3% | -5.1% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 10.4% | 12.5% | 14.9% | -3.1% | 6.1% | 8.6% | ||
Prior Fiscal Year | 9.4% | 12.9% | -6.2% | 4.0% | 4.2% | 3.8% | ||
Latest Fiscal Year | 10.6% | 14.7% | 2.0% | -6.5% | 5.1% | 5.9% | ||
Latest Twelve Months | 10.6% | 14.7% | 2.0% | -6.5% | 4.4% | 5.9% | ||
Current Trading Multiples | ||||||||
EV / LTM EBITDA | 18.1x | 24.9x | 17.1x | 7.2x | 12.1x | 7.5x | ||
Price / LTM Sales | 2.9x | 5.0x | 2.0x | 1.3x | 0.9x | 0.7x | ||
LTM P/E Ratio | 27.0x | 34.1x | 100.4x | -20.2x | 21.0x | 12.4x | ||
Low | Mid | High | ||||||
Benchmark LTM P/S Ratio | 0.9x | 2.0x | 5.0x | |||||
Historical LTM P/S Ratio | 0.7x | 1.0x | 1.5x | |||||
Selected Price / Sales Multiple | 0.9x | 1.0x | 1.0x | |||||
(x) LTM Sales | 4,152 | 4,152 | 4,152 | |||||
(=) Equity Value | 3,906 | 4,112 | 4,317 | |||||
(/) Shares Outstanding | 328.3 | 328.3 | 328.3 | |||||
Implied Value Range | 11.90 | 12.52 | 13.15 | |||||
FX Rate: CHF/CHF | 1.0 | 1.0 | 1.0 | Market Price | ||||
Implied Value Range (Trading Cur) | 11.90 | 12.52 | 13.15 | 9.26 | ||||
Upside / (Downside) | 28.6% | 35.3% | 42.1% |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | SIKA | GIVN | DSFIR | E3E | AKZA | CLNz | |
Value of Common Equity | 33,581 | 37,200 | 25,111 | 947 | 9,786 | 3,038 | |
(/) Shares Outstanding | 160.4 | 9.2 | 264.3 | 590.0 | 170.9 | 328.3 | |
Implied Stock Price | 209.30 | 4,032.00 | 95.02 | 1.61 | 57.26 | 9.26 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.13 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 209.30 | 4,032.00 | 95.02 | 1.42 | 57.26 | 9.26 | |
Trading Currency | CHF | CHF | EUR | EUR | EUR | CHF | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.13 | 1.00 | 1.00 |